New obesity drug tirzepatide put to the test in paraguay clinic
Disease control
Not yet recruiting
This study will test the safety and effectiveness of tirzepatide, a once-weekly injection, in 300 adults with obesity or overweight plus related health problems. Participants will receive increasing doses over 12 months while doctors track side effects, weight loss, and improveme…
Sponsor: LABORATORIOS INDUFAR • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC